The U.S. Food and Drug Administration (FDA) on Saturday reissued an emergency use authorization to Quest Diagnostics to authorize a coronavirus test with pooled samples. In an FDA news release, ...
Quest Diagnostics will soon begin offering a new blood-based in-vitro diagnostic test for Alzheimer’s. The disease affects nearly 7 million Americans. The Lumipulse G pTau 217/β-Amyloid 1-42 Plasma ...
In an oral presentation at the 2025 AAN Annual Meeting, Quest scientists presented data suggesting the test can accurately assess Alzheimer's disease pathology with greater than 90% sensitivity and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results